SGMOQ compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

SGMOQSangamo Therapeutics, Inc

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

SGMOQSangamo Therapeutics, Inc

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

SGMOQSangamo Therapeutics, Inc

Mkt cap$48.1MRevenue$1MQ1 FY26Revenue$40MFY25

AMGNAmgen Inc

466.31▲+1.21%· post 466.40

ClosedOct 30 '26

Mkt cap$251.9BRevenue$10.1BQ2 FY26Revenue$36.8BFY25

Compare

ClosedOct 30 '26

SGMOQSangamo Therapeutics, Inc

AMGNAmgen Inc

Price

466.31▲+1.21%post 466.40

$48.1M

Mkt cap

$251.9B

Q1 FY26$1M

Revenue

$10.1BQ2 FY26

FY25$40M

Revenue

$36.8BFY25

SGMOQvsAMGN466.31▲+1.21%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

SGMOQ: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SGMOQ 4

—Alexion Pharmaceuticalsunlistedcustomer

—Astellas Gene Therapiesunlistedcustomer

—Eli Lillyunlistedcustomer

—Genentechunlistedcustomer

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›

Price

rebased to 0%

SGMOQ, solidAMGN, dashed